ciqorin 100 mg mīkstās kapsulas
teva pharma b.v., netherlands - ciklosporīns - mīkstās kapsulas - 100 mg
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastiski līdzekļi - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
sunitinib g.l. pharma 12,5 mg cietās kapsulas
g.l. pharma gmbh, austria - sunitinibs - kapsula, cietā - 12,5 mg
sunitinib g.l. pharma 25 mg cietās kapsulas
g.l. pharma gmbh, austria - sunitinibs - kapsula, cietā - 25 mg
sunitinib g.l. pharma 50 mg cietās kapsulas
g.l. pharma gmbh, austria - sunitinibs - kapsula, cietā - 50 mg
sunitinib zentiva 12,5 mg cietās kapsulas
zentiva, k.s., czech republic - sunitinibs - kapsula, cietā - 12,5 mg
sunitinib zentiva 50 mg cietās kapsulas
zentiva, k.s., czech republic - sunitinibs - kapsula, cietā - 50 mg
sunitinib krka 25 mg cietās kapsulas
krka, d.d., novo mesto, slovenia - sunitinibs - kapsula, cietā - 25 mg
sunitinib krka 50 mg cietās kapsulas
krka, d.d., novo mesto, slovenia - sunitinibs - kapsula, cietā - 50 mg
sunitinib norameda 12,5 mg cietās kapsulas
norameda uab, lithuania - sunitinibs - kapsula, cietā - 12,5 mg